Correlation of interferon‐inducible chemokine plasma levels with disease severity in systemic sclerosis

• Published in: Arthritis & rheumatology (Hoboken, N.J.) Vol. 65; no. 1; pp. 226 - 235
• Main Authors: Liu, Xiaochun, Mayes, Maureen D., Tan, Filemon K., Wu, Minghua, Reveille, John D., Harper, Brock E., Draeger, Hilda T., Gonzalez, Emilio B., Assassi, Shervin
• Format: Journal Article
• Language: English
• Published: Hoboken Wiley Subscription Services, Inc., A Wiley Company 01.01.2013; Wiley Subscription Services, Inc
• Subjects: Adolescent; Adult; Aged; Aged, 80 and over; Biomarkers; Chemokines; Chemokines - blood; Child; Disease; Female; Humans; Interferons - metabolism; Male; Middle Aged; Plasma; Prognosis; RNA polymerase; Scleroderma, Systemic - immunology; Scleroderma, Systemic - metabolism; Severity of Illness Index; Transcriptome; Young Adult
• ISSN: 0004-3591; 2326-5191; 1529-0131; 1529-0131; 2326-5205
• DOI: 10.1002/art.37742

Objective To measure interferon (IFN)–inducible chemokines in the plasma of patients with systemic sclerosis (SSc) and investigate whether the chemokine levels are correlated with disease severity. Methods Plasma levels of the IFN‐inducible chemokines IFNγ‐inducible protein 10 (IP‐10/CXCL10), IFN‐in...